Highlights SK bioscience Co.,Ltd.

Equities

A302440

KR7302440003

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-07-04 pm EDT			5-day change	1st Jan Change
52,700 ^KRW	+1.35%		+0.19%	-26.81%

Jun. 28	SK Bioscience to Take Over Germany's IDT Biologika	MT
Jun. 27	South Korean shares fall but chipmakers' rebound limits early losses	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SK Bioscience to Take Over Germany's IDT Biologika	Jun. 28	MT
South Korean shares fall but chipmakers' rebound limits early losses	Jun. 26	RE
SK Bioscience Shares Surge After Acquisition Plan	Jun. 26	DJ
South Korea's SK Bioscience to buy control of Germany's IDT Biologika for $244 mln	Jun. 26	RE
SK Bioscience's Attributable Loss Narrows in Q1	May. 03	MT
SK Bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline	Mar. 07	CI
SK Bioscience Obtains Prequalification Certification from the World Health Organization	Feb. 23	CI
SK Bioscience's Net Income Plunges in Q4	Feb. 02	MT
SK Bioscience to Expand Facilities to Develop New Pneumococcal Vaccine	Nov. 30	MT
SK Group Advances Net Zero Transition via Key Renewable Energy Deal	Nov. 27	MT
SK Bioscience, Hilleman Laboratories Partner on Second-Gen Ebola Virus Vaccine	Nov. 22	MT
SK Bioscience Swings to Loss in Q2	23-07-31	MT
SK Bioscience and Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate	23-06-29	CI
SK Bioscience Swings to Loss in Q1; Shares Jump 15%	23-05-03	MT
SK Bioscience Swings to Loss in Q1	23-04-28	MT
SK Bioscience's Q4 Profit Plunges 85%	23-02-13	MT
SK Biopharmaceuticals Swings to Loss in Q4	23-02-09	MT
SK Bioscience to Establish Songdo Global Research & Process Development Center	23-02-08	CI
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs	23-01-27	CI
SK Bioscience Co.,Ltd. Receives Expanded Manufacturing and Marketing Approval from the Korean Ministry of Food and Drug Safety for Nuvaxovid	23-01-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights SK bioscience Co.,Ltd.

Equities

A302440

KR7302440003

Highlights

Filters